Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
French ccAFU guidelines - update 2020-2022: retroperitoneal sarcoma
Ist Teil von
Progrès en urologie (Paris), 2020-11, Vol.30 (12S), p.S314-S330
Ort / Verlag
France
Erscheinungsjahr
2020
Quelle
Elsevier ScienceDirect Journals Complete
Beschreibungen/Notizen
- To update French urological guidelines on retroperitoneal sarcoma.
- Comprehensive Medline search between 2018 and 2020 upon diagnosis, treatment and follow-up of retroperitoneal sarcoma. Level of evidence was evaluated.
- Chest, abdomen and pelvis CT is mandatory to evaluate any suspected retroperitoneal sarcoma. MRI sometimes helps surgical planning. Before histological confirmation through biopsy, the patient must be registered in the French sarcoma pathology reference network. The biopsy standard should be an extraperitoneal coaxial percutaneous sampling before any retroperitoneal mass therapeutic decision. Surgery is retroperitoneal sarcoma cornerstone. The main objective is grossly negative margins and can be technically challenging. Multimodal treatment risks and benefits must be discussed in multidisciplinary teams. The relapse rate is related to tumor grade and surgical margins. Reported Negative margins rate thus encourage surgery in high-volume centers.
- Retroperitoneal sarcoma prognosis is poor and closely related to the quality of initial management. Centralization through dedicated sarcoma pathology network in a high-volume center is mandatory.
Sprache
Französisch
Identifikatoren
ISSN: 1166-7087
DOI: 10.1016/S1166-7087(20)30755-7
Titel-ID: cdi_proquest_miscellaneous_2472107220
Format
–
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von bX